| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 530* | 2021 |
| Incidence of thyroid-related adverse events in melanoma patients treated with pembrolizumab J de Filette, Y Jansen, M Schreuer, H Everaert, B Velkeniers, B Neyns, ... The Journal of Clinical Endocrinology & Metabolism 101 (11), 4431-4439, 2016 | 230 | 2016 |
| Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600-mutant melanoma: an open-label, single arm, dual-centre, phase 2 … M Schreuer, Y Jansen, S Planken, I Chevolet, T Seremet, V Kruse, ... The Lancet Oncology 18 (4), 464-472, 2017 | 204 | 2017 |
| Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma YJL Jansen, EA Rozeman, R Mason, SM Goldinger, MHG Foppen, ... Annals of Oncology 30 (7), 1154-1161, 2019 | 194 | 2019 |
| Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with … M Schreuer, G Meersseman, S Van Den Herrewegen, Y Jansen, ... Journal of translational medicine 14, 1-11, 2016 | 153 | 2016 |
| Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy T Seremet, Y Jansen, S Planken, H Njimi, M Delaunoy, H El Housni, ... Journal of translational medicine 17, 1-13, 2019 | 107 | 2019 |
| SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. C COVIDSurg, C GlobalSurg Anaesthesia 77 (1), 28-39, 2022 | 98 | 2022 |
| A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV … Y Jansen, V Kruse, J Corthals, K Schats, PJ van Dam, T Seremet, ... Cancer Immunology, Immunotherapy 69, 2589-2598, 2020 | 56 | 2020 |
| Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ... Anaesthesia 76 (11), 1454-1464, 2021 | 42 | 2021 |
| Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib YJ Jansen, P Janssens, A Hoorens, MS Schreuer, T Seremet, ... Melanoma Research 25 (6), 550-554, 2015 | 40 | 2015 |
| Yersinia ruckeri, an unusual microorganism isolated from a human wound infection S De Keukeleire, A De Bel, Y Jansen, M Janssens, G Wauters, D Piérard New microbes and new infections 2 (4), 134-135, 2014 | 34 | 2014 |
| Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients T Seremet, A Koch, Y Jansen, M Schreuer, S Wilgenhof, V Del Marmol, ... Journal of translational medicine 14, 1-14, 2016 | 32 | 2016 |
| A comprehensive analysis of baseline clinical characteristics and biomarkers associated with outcome in advanced melanoma patients treated with pembrolizumab G Awada, Y Jansen, JK Schwarze, J Tijtgat, L Hellinckx, O Gondry, ... Cancers 13 (2), 168, 2021 | 25 | 2021 |
| Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases YJL Jansen, G Verset, K Schats, PJ Van Dam, T Seremet, M Kockx, ... ESMO open 4 (2), e000464, 2019 | 25 | 2019 |
| Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from … T Seremet, S Planken, M Schreuer, Y Jansen, M Delaunoy, H El Housni, ... Melanoma research 28 (1), 65-70, 2018 | 23 | 2018 |
| Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries JC Glasbey, TEF Abbott, A Ademuyiwa, A Adisa, E AlAmeer, S Alshryda, ... The Lancet 400 (10363), 1607-1617, 2022 | 22 | 2022 |
| Applications for quantitative measurement of BRAF V600 mutant cell-free tumor DNA in the plasma of patients with metastatic melanoma M Schreuer, G Meersseman, S van Den Herrewegen, Y Jansen, ... Melanoma Research 26 (2), 157-163, 2016 | 18 | 2016 |
| Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanoma T Seremet, S Planken, JK Schwarze, Y Jansen, L Vandeweerd, ... Melanoma Research 29 (1), 85-88, 2019 | 17 | 2019 |
| Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries British Journal of Surgery 110 (7), 804-817, 2023 | 13 | 2023 |
| The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition: A multicentre retrospective analysis JM Versluis, AM Hendriks, AM Weppler, LJ Brown, K de Joode, ... European Journal of Cancer 151, 72-83, 2021 | 13 | 2021 |
